SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-15-073305
Filing Date
2015-12-30
Accepted
2015-12-30 13:30:28
Documents
2
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR GROUP, LLCHEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE II GP, LLCHEALTHCOR OFFSHORE MASTER FUND, L.P.HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P.JOSEPH HEALEY

Document Format Files

Seq Description Document Type Size
1 SC 13G v427910_sc13g.htm SC 13G 148407
2 EXHIBIT 1 v427910_ex1.htm EX-99.1 13767
  Complete submission text file 0001144204-15-073305.txt   164168
Mailing Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019 212-622-7731
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

IRS No.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Subject) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-86638 | Film No.: 151313045
SIC: 2834 Pharmaceutical Preparations